Biopharmaceutical company Propanc Biopharma announced today its plans to acquire $100 million worth of Ethereum over the next 12 months. The company said the move will enhance its corporate strategy across various sectors, including cryptocurrency investment, drug development, and asset acquisition. (Globenewswire)